LB1581 Sex Differences in Adverse Event Reporting During Treatment With TNF-alpha Inhibitors for Psoriasis

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2018.06.118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Adverse Events Associated With Pediatric Use of Proton Pump Inhibitors: Analysis of the Fda Adverse Event Reporting System

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Application of TNF-alpha Inhibitors in Treatment of Uveitis Associated With Ankylosing Spondylitis

Vestnik Oftalmologii
MedicineOphthalmology
2018English

TNF-alpha Inhibitors: Current Indications

Indian Journal of Critical Care Medicine
Critical CareIntensive Care Medicine
2007English

Seasonal and Geographic Variation in Adverse Event Reporting

Drugs - Real World Outcomes
Pharmacology
2016English

Adverse Event Reporting in Studies of Penetrating Acupuncture During Pregnancy: A Systematic Review

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2015English

Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2018English

Pharmacy Student Perceptions of Adverse Event Reporting

American Journal of Pharmaceutical Education
PharmacologyPharmacyMedicineToxicologyEducationPharmaceutics
2011English

Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia

JAMA Dermatology
DermatologyMedicine
2015English

Clinical Follow‐up of Uveitis Patients Treated With TNF‐alpha Inhibitors and Causes of Treatment Discontinuation

Acta Ophthalmologica
MedicineOphthalmology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy